RE:Name changeLiveMethod wrote:
so couldn't sell because of name change. I didn't read all the replies to my last post. But I've been holding onto valens since the beginning. And last like 2 years this stock has done f all. It shows promise, then falls. And everytime we get a good bump boom everyone starts selling. I just feel like are we all just wishful that this stock will be an $8 stock soon? It shows no evidence that thats ever going to happen. The latest price quote by end of year by someone cant remember his name. But he said $4. When I think about it he's probably close. More accurate than $8 I believe. Ya i am a more hype investor. If I see alot movement on a stock, I get very excited about possible potential. And makes me look at my valens shares that do nothing for me. And when it goes up now I don't get excited, because it only lasts a day and then we're back down to earth again. Its becoming a trend. And makes me think. Will this stock ever take off? If u asked me a year ago I would say yes. Now I honestly don't know anymore. I thought going to the tsx would change everything. Alot of news. I kind of think these pot stocks are losing traction. Deep down I want valens to succeed and be the best. But when will it happen?
Public markets with liquidity allow price discovery. Imo Valens has simply been suffering from having to turn over some of the long-gone founders' shares, from time to time. From discussions had, the general concensus seems to be that no one really wants to sell their shares, given the growth profile and expectations, but life gets in the way and time relentlessly ticks on.
Keep in mind, price discovery is not the same as valuation. Where price discovery is a market driven mechanism, valuation is a model driven mechanism. Valuation is the present value of presumed cash flows, interest rates, competitive analysis, technological changes both in place and envisioned, and many other factors.
Other names for valuation of an asset are
fair value and
intrinsic value. By comparing market value to valuation, analysts can determine if an asset is overpriced or underpriced by the market. Of course, the
market price is the actual correct price, but any differences may provide trading opportunities if and when the market price adjusts to include any information in the valuation models not previously considered.
Having said all that, Valens is a real gem, and exceptionally well-positioned to become one of the true growth stories in the cannabis sector. One of the big players out there, with more cash than bench strength (as it turns out), would gain tremendously from acquiring Valens while its shares are weak. That is management's greatest fear.
The Valens platform is exceptional, has several proprietary elements, and the advantage of an excellent reputation not easily duplicated. Lots of cash, no debt, and consistently profitable with growing revenue. They've built a solid team.
A $5+ bid is, imo, long overdue and I'm surprised no one has come at them yet. Of course, such a low-ball bid may bring out a competitive bidder, but I can't imagine there aren't interested parties in the wings, maybe even active in the market - softening up the retail shareholders' resolve ;-)